The pro-inflammatory potential of T cells in juvenile-onset systemic lupus erythematosus

Pediatric Rheumatology

Volumn 12, Issue 1, 2014, Pages

  Ballantine, Lucy E ^a   Ong, Joanne ^a   Midgley, Angela ^a   Watson, Louise ^a   Flanagan, Brian F ^a   Beresford, Michael W ^a,b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b ALDER HEY CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

IL 17A; Juvenile onset systemic lupus erythematosus; Lupus; Th17

Indexed keywords

AZATHIOPRINE; C REACTIVE PROTEIN; CD28 ANTIGEN; CD3 ANTIGEN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; DOUBLE STRANDED DNA ANTIBODY; HYDROXYCHLOROQUINE; INTERLEUKIN 17; INTERLEUKIN 21; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 23 RECEPTOR; INTERLEUKIN 6; MESSENGER RNA; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RETINOID RELATED ORPHAN RECEPTOR GAMMA; RITUXIMAB;

ADOLESCENT; ARTICLE; CELL CULTURE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE DURATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; HUMAN CELL; INFLAMMATION; JUVENILE ONSET SYSTEMIC LUPUS ERYTHEMATOSUS; MALE; ONSET AGE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; SLEDAI; SUPERNATANT; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; TH1 TH2 BALANCE; TH17 CELL; VISUAL ANALOG SCALE; BIOSYNTHESIS; BLOOD; DISEASE COURSE; LUPUS ERYTHEMATOSUS, SYSTEMIC; METABOLISM; MONONUCLEAR CELL; PATHOPHYSIOLOGY; T LYMPHOCYTE SUBPOPULATION;

ADOLESCENT; AGE OF ONSET; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-17; LEUKOCYTES, MONONUCLEAR; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; T-LYMPHOCYTE SUBSETS; TH17 CELLS;

EID: 84892386145     PISSN: None     EISSN: 15460096     Source Type: Journal    
DOI: 10.1186/1546-0096-12-4     Document Type: Article

References (23)

1. Papadimitraki ED, Isenberg DA. Childhood- and adult-onset lupus: an update of similarities and differences. Expert Rev Clin Immunol 2009, 5(4):391-403. 10.1586/eci.09.29, 20477036.
2. Brunner HI, et al. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus. Arthritis Rheum 2008, 58(2):556-562. 10.1002/art.23204, 18240232.
3. Funauchi M, et al. Decreased Th1-like and increased Th2-like cells in systemic lupus erythematosus. Scand J Rheumatol 1998, 27(3):219-224. 10.1080/030097498440859, 9645418.
4. Ma J, et al. The imbalance between regulatory and IL-17-secreting CD4+ T cells in lupus patients. Clin Rheumatol 2010, 29(11):1251-1258. 10.1007/s10067-010-1510-7, 20563617.
5. Mesquita D, et al. Systemic lupus erythematosus exhibits a dynamic and continuum spectrum of effector/regulatory T cells. Scand J Rheumatol 2011, 40(1):41-50. 10.3109/03009742.2010.489229, 20936986.
6. Yang J, et al. Th17 and natural Treg cell population dynamics in systemic lupus erythematosus. Arthritis Rheum 2009, 60(5):1472-1483. 10.1002/art.24499, 19404966.
7. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996, 383(6603):787-793. 10.1038/383787a0, 8893001.
8. Mortensen ES, Fenton KA, Rekvig OP. Lupus nephritis: the central role of nucleosomes revealed. Am J Pathol 2008, 172(2):275-283. 10.2353/ajpath.2008.070563, 2312358, 18187568.
9. Theofilopoulos AN, et al. The role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity. Arthritis Res 2001, 3(3):136-141. 10.1186/ar290, 128889, 11299053.
10. Shah K, et al. Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus. Arthritis Res Ther 2010, 12(2):R53. 10.1186/ar2964, 2888202, 20334681.
11. Dolff S, et al. Disturbed Th1, Th2, Th17 and T(reg) balance in patients with systemic lupus erythematosus. Clin Immunol 2011, 141(2):197-204. 10.1016/j.clim.2011.08.005, 21920821.
12. Henriques A, et al. Frequency and functional activity of Th17, Tc17 and other T-cell subsets in Systemic Lupus Erythematosus. Cell Immunol 2010, 264(1):97-103. 10.1016/j.cellimm.2010.05.004, 20553755.
13. Xing Q, et al. Elevated Th17 cells are accompanied by FoxP3+ Treg cells decrease in patients with lupus nephritis. Rheumatol Int 2012, 32(4):949-958. 10.1007/s00296-010-1771-0, 21243492.
14. Hochberg MC. Updating the american college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997, 40(9):1725.
15. Marks SD, et al. The use of the British Isles Lupus Assessment Group (BILAG) index as a valid tool in assessing disease activity in childhood-onset systemic lupus erythematosus. Rheumatology (Oxford) 2004, 43(9):1186-1189. 10.1093/rheumatology/keh284, 15226518.
16. Akahoshi M, et al. Th1/Th2 balance of peripheral T helper cells in systemic lupus erythematosus. Arthritis Rheum 1999, 42(8):1644-1648. 10.1002/1529-0131(199908)42:8<1644::AID-ANR12>3.0.CO;2-L, 10446863.
17. Hoffman IE, et al. Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus. Ann Rheum Dis 2009, 68(3):412-415. 10.1136/ard.2008.094813, 18930995.
18. Edelbauer M, et al. Activity of childhood lupus nephritis is linked to altered T cell and cytokine homeostasis. J Clin Immunol 2012, 32(3):477-487. 10.1007/s10875-011-9637-0, 22228566.
19. Li Y, et al. Methotrexate attenuates the Th17/IL-17 levels in peripheral blood mononuclear cells from healthy individuals and RA patients. Rheumatol Int 2012, 32(8):2415-2422. 10.1007/s00296-011-1867-1, 21691744.
20. Lina C, et al. Combined treatment of etanercept and MTX reverses Th1/Th2, Th17/Treg imbalance in patients with rheumatoid arthritis. J Clin Immunol 2011, 31(4):596-605. 10.1007/s10875-011-9542-6, 21562776.
21. Wang Y, et al. Laser microdissection-based analysis of cytokine balance in the kidneys of patients with lupus nephritis. Clin Exp Immunol 2010, 159(1):1-10. 10.1111/j.1365-2249.2009.04031.x, 2802690, 19807734.
22. Oh SH, et al. Expression of interleukin-17 is correlated with interferon-alpha expression in cutaneous lesions of lupus erythematosus. Clin Exp Dermatol 2011, 36(5):512-520. 10.1111/j.1365-2230.2010.03996.x, 21631571.
23. Pascual V, Farkas L, Banchereau J. Systemic lupus erythematosus: all roads lead to type I interferons. Curr Opin Immunol 2006, 18(6):676-682. 10.1016/j.coi.2006.09.014, 17011763.